6088
F. Matloubi Moghaddam, H. Zali Boinee / Tetrahedron 60 (2004) 6085–6089
derivatives have promising analgesic and anti-inflammatory
effect.
Compound 3b: white powder (EtOH), mp: 145 8C, 1H
NMR (CDCl3, 500 MHz) 7.36 (d, J¼8.4 Hz, 2H), 7.26
(d, J¼8.5 Hz, 2H), 7.18 (d, J¼8.5 Hz, 2H), 6.95 (d,
J¼8.4 Hz, 2H), 6.87 (s, 1H), 3.68 (t, J¼4.6 Hz, 4H), 2.86
(t, J¼4.6 Hz, 4H); IR (KBr) 3050, 2953, 1584, 1500, 1123,
830 (cm21).
In conclusion we have developed a new general efficient and
simple method for the preparation of highly substituted
thiophenes. The generality of the method has been
demonstrated by the successful conversion of twelve
substrates into tri or tetra substituted morpholino thiophenes
in good yields. The base is rather cheap and readily
available in all chemistry laboratories. The method was
easily extended to the synthesis of thiophenes (see Table 2)
bearing an acetic acid unit at position 5. These materials
especially 2-morpholino-5-acetic acid substituted thio-
phenes have the potential to be used as analgesic and
anti-inflammatory drugs. The methodology described here
seems to be the simplest one for the one-step synthesis of
these compounds.
Compound 3c: light yellow crystals (EtOH), mp: 153 8C, 1H
NMR (CDCl3, 500 MHz) 7.65 (d, J¼8.2 Hz, 2H), 7.55 (d,
J¼8.0 Hz, 2H), 7.46 (t, J¼7.6 Hz, 2H), 7.36 (t, J¼8.1 Hz,
1H), 7.34 (d, J¼8.1 Hz, 2H2), 7.31 (d, J¼8.0 Hz, 2H), 7.01
(d, J¼8.2 Hz, 2H), 6.88 (s, 1H), 3.70 (t, J¼4.4 Hz, 4H), 2.91
(t, J¼4.5 Hz, 4H); IR (KBr) 3060, 2845, 1638, 1500, 1123,
830 (cm21).
Compound 3d: yellow powder (EtOH), mp: 157 8C, 1H
NMR (CDCl3, 500 MHz) 7.83 (d, J¼7.3 Hz, 1H), 7.77,
(d, J¼8.5 Hz, 1H), 7.72 (d, J¼8.5 Hz, 1H), 7.70 (s, 1H),
7.45–7.50 (m, 2H), 7.41 (d, d, J¼8.4, 1.5 Hz, 1H), 7.29 (d,
J¼8.5 Hz, 2H), 6.98 (d, J¼8.5 Hz, 2H), 6.90 (s, 1H), 3,64 (t,
J¼4.5 Hz, 4H), 2.89 (t, J¼4.5 Hz, 4H); IR (KBr) 3110,
2950, 1610, 1445, 1123, 700 (cm21).
2. Experimental
The compounds gave satisfactory all spectroscopic data. FT
IR spectra were recorded as KBr pellets on a Nicolet
spectrometer (Magna 550). A Bruker (DRX-500 Avance)
NMR was used to record the 1H NMR spectra. All 1H NMR
spectra were determined in CDCl3 at ambient temperature.
Melting points were determined on a Bu¨chi B540 apparatus.
Compound 3e: white powder (EtOH), mp: 208 8C, 1H NMR
(CDCl3, 500 MHz) 7.13–7.24 (m, 13H), 6.96 (d, d, J¼7.4,
1.8 Hz, 2H), 3.61 (t, J¼4.6 Hz, 4H), 2.88 (t, J¼4.6 Hz, 4H);
IR (KBr) 3090, 2970, 1620, 1500, 1123, 700 (cm21).
Compound 3f: yellow powder (EtOH), mp: 214 8C, 1H
NMR (CDCl3, 500 MHz) 7.14–7.23 (m, 8H), 7.10 (d, J¼
8.7 Hz, 2H), 6.97 (d, d, J¼7.3, 2 Hz, 2H), 6.79 (d, J¼
8.7 Hz, 2H), 3.62 (t, J¼4.6 Hz, 4H), 2.89 (t, J¼4.6 Hz, 4H);
IR (KBr) 3120, 2845, 1600, 1507, 1123, 753 (cm21).
2.1. General procedure for the one-pot preparation of
compounds (a–i)
To a stirred solution of thiomorpholide (4 mmol) in toluene
(5 ml), anhydrous K2CO3 (0.552 g, 4 mmol) was added.
Then a solution of bromoketone (4 mmol) in toluene
(,3 ml) was added dropwise over 10 min. The reaction
mixture was heated at 75 8C for about 7 h. The solvent was
evaporated to half volume. After cooling a precipitate was
appeared. The precipitate was filtered and crystallized from
a suitable solvent.
Compound 3g: light yellow powder (EtOH), mp: 243 8C, 1H
NMR (CDCl3, 500 MHz) 7.75 (d, J¼7.7 Hz, 1H), 7.65 (d,
J¼8.5 Hz, 1H), 7.60 (d, J¼7.8 Hz, 1H), 7.58 (s, 1H), 7.40–
7.43 (m, 2H), 7.38 (d, J¼8.5 Hz, 1H), 7.13–7.23 (m, 5H),
7.07–7.11 (m, 3H), 6.96 (d, J¼6.5 Hz, 2H), 3.64 (t, J¼
4.4 Hz, 4H), 2.93 (t, J¼4.4 Hz, 4H); IR (KBr) 3097, 2807,
1607, 1500, 1253, 836 (cm21).
2.2. General procedure for the one-pot preparation of
compounds (j–l)
Compound 3h: light yellow crystals (EtOH), mp: 196 8C, 1H
NMR (CDCl3, 500 MHz) 7.1–7.18 (m, 8H), 7.06 (d, J¼
8.6 Hz, 2H), 6.93 9m, 2H), 6.71 (d, J¼8.6 Hz, 2H), 3.79 (s,
3H), 3.69 (t, J¼4.4 Hz, 4H), 2.94 (t, J¼4.5 Hz, 4H); IR
(KBr) 3090, 2856, 1597, 1502, 1125, 830 (cm21).
To a stirred solution of thiomorpholide (4 mmol) in 2-pro-
panol (3 ml), b-bromo-b-benzoyl propionic acid (4 mmol)
was added. Then reaction mixture was heated to 70 8C for
about 1 h. Then, anhydrous Na2CO3 (0.212 g, 2 mmol) was
added and stirred overnight. The solvent was removed under
vacuum and the residue was dissolved in ether (20 ml),
washed with 2£5 ml NaOH (5%). The aqueous solution was
acidified with HCl (5%) and extracted with diethyl ether.
The solvent was evaporated and the solid residue was
recrystallized from ethanol.
Compound 3i: white crystals (EtOH), mp: 105 8C, 1H NMR
(CDCl3, 500 MHz) 7.79 (d, J¼7.7 Hz, 2H), 7.41 (t, J¼
7.7 Hz, 2H), 7.27 (t, J¼7.6 Hz, 1H), 6.79 (s, 1H), 3.81 (t,
J¼4.6 Hz, 4H), 2.97 (t, J¼4.6 Hz, 4H), 2.48 (s, 3H); IR
(KBr) 2964, 2907, 2860, 1643, 1505, 1117, 837 (cm21).
Compound 3j: white powder (EtOH), mp: 172 8C, 1H NMR
(CDCl3, 500 MHz) 9.45 (s, 1H), 7.24 (m, 3H), 7.11–7.19
(m, 5H), 7.05 (m, 2H), 3.72 (s, 2H), 3.67 (t, J¼4.5 Hz, 4H),
2.89 (t, J¼4.5 Hz, 4H); IR (KBr) 3738, 3050, 2923, 1707,
1446, 1253, 759 (cm21).
2.3. Spectroscopic data for compounds (3a–3m)
Compound 3a: white powder (EtOH), mp: 178 8C, 1H NMR
(CDCl3, 500 MHz) 7.33 (d, J¼8.2 Hz, 2H), 7.29 (d, J¼
9.4 Hz, 2H), 7.27 (t, J¼5.4 Hz, 1H), 7.23 (t, J¼5.4 Hz, 2H),
6.96 (d, J¼8.2 Hz, 2H), 6.86 (s, 1H), 3.67 (t, J¼4.3 Hz, 4H),
2.87 (t, J¼4.3 Hz, 4H); IR (KBr) 3100, 2915, 1645, 1500,
1123, 830 (cm21).
Compound 3k: light yellow powder (EtOH), mp: 228 8C, 1H
NMR (CDCl3, 500 MHz) 9.52 (s, 1H), 7.26 (m, 3H), 7.15 (d,
J¼8.5 Hz, 2H), 7.1 (d, J¼8.5 Hz, 2H), 7.02–7.04 (m, 2H),